Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

B lymphocytes in anti-mycobacterial immune responses: Pathogenesis or protection?

Dyatlov AV, Apt AS, Linge IA.

Tuberculosis (Edinb). 2019 Jan;114:1-8. doi: 10.1016/j.tube.2018.10.011. Epub 2018 Oct 28. Review.

PMID:
30711147
2.

A new model for chronic and reactivation tuberculosis: Infection with genetically attenuated Mycobacterium tuberculosis in mice with polar susceptibility.

Kondratieva TK, Kapina MA, Rubakova EI, Kondratieva EV, Nikonenko BV, Majorov KB, Dyatlov AV, Linge IA, Apt AS.

Tuberculosis (Edinb). 2018 Dec;113:130-138. doi: 10.1016/j.tube.2018.10.003. Epub 2018 Oct 10.

PMID:
30514495
3.

Overexpression of Adenylyl Cyclase Encoded by the Mycobacterium tuberculosis Rv2212 Gene Confers Improved Fitness, Accelerated Recovery from Dormancy and Enhanced Virulence in Mice.

Shleeva MO, Kondratieva TK, Demina GR, Rubakova EI, Goncharenko AV, Apt AS, Kaprelyants AS.

Front Cell Infect Microbiol. 2017 Aug 17;7:370. doi: 10.3389/fcimb.2017.00370. eCollection 2017.

4.

Host genetics in susceptibility to and severity of mycobacterial diseases.

Apt AS, Logunova NN, Kondratieva TK.

Tuberculosis (Edinb). 2017 Sep;106:1-8. doi: 10.1016/j.tube.2017.05.004. Epub 2017 May 27. Review.

PMID:
28802396
5.

"Suppressor Factor" of Neutrophils: A Short Story of a Long-Term Misconception.

Linge IA, Kondratieva EV, Kondratieva TK, Makarov VA, Polshakov VI, Savelyev OY, Apt AS.

Biochemistry (Mosc). 2016 Nov;81(11):1284-1292.

6.

In Vitro Activity of 3-Triazeneindoles against Mycobacterium tuberculosis and Mycobacterium avium.

Nikonenko BV, Kornienko A, Majorov K, Ivanov P, Kondratieva T, Korotetskaya M, Apt AS, Salina E, Velezheva V.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):6422-4. doi: 10.1128/AAC.00998-16. Print 2016 Oct.

7.

Formation of compact aggregates of B-lymphocytes in lung tissue during mycobacterial infection in mice depends on TNF production by these cells and is not an element of the host's immunological protection.

Kondratieva TK, Linge IA, Kondratieva EV, Dyatlov AV, Drutskaya MS, Zvartsev RV, Nedospasov SA, Apt AS.

Biochemistry (Mosc). 2014 Dec;79(12):1358-62. doi: 10.1134/S0006297914120098.

8.

Capacity of lung stroma to educate dendritic cells inhibiting mycobacteria-specific T-cell response depends upon genetic susceptibility to tuberculosis.

Kapina MA, Rubakova EI, Majorov KB, Logunova NN, Apt AS.

PLoS One. 2013 Aug 15;8(8):e72773. doi: 10.1371/journal.pone.0072773. eCollection 2013.

9.

Mycobacterium tuberculosis Transcriptome Profiling in Mice with Genetically Different Susceptibility to Tuberculosis.

Skvortsov TA, Ignatov DV, Majorov KB, Apt AS, Azhikina TL.

Acta Naturae. 2013 Apr;5(2):62-9.

10.

Drug testing in mouse models of tuberculosis and nontuberculous mycobacterial infections.

Nikonenko BV, Apt AS.

Tuberculosis (Edinb). 2013 May;93(3):285-90. doi: 10.1016/j.tube.2013.02.010. Epub 2013 Mar 11. Review.

PMID:
23491715
11.

[Production of mycobacterial antigenes merged with cellulose binding protein domain in order to produce subunit vaccines against tuberculosis].

Sergienko OV, Liashchuk AM, Aksenova EI, Galushkina ZM, Poletaeva NN, Sharapova NE, Semikhin AS, Kotnova AR, Veselov AM, Bashkirov VN, Kulikova NL, Khlebnikov VS, Kondrat'eva TK, Kariagina-Zhulina AS, Apt AS, Lunin VG, Gintsburg AL.

Mol Gen Mikrobiol Virusol. 2012;(1):16-20. Russian.

PMID:
22702139
12.

[Prevention of tuberculosis: current approaches to development of vaccines].

Stukova MA, Zabolotnykh NV, Vinogradova TI, Gergert VIa, Apt AS, Kaprel'iants AS, Erokhin VV, Iablonskiĭ PK, Kiselev OI.

Vestn Ross Akad Med Nauk. 2012;(11):45-52. Review. Russian.

PMID:
23457981
13.

Are mouse models of human mycobacterial diseases relevant? Genetics says: 'yes!'.

Apt AS.

Immunology. 2011 Oct;134(2):109-15. doi: 10.1111/j.1365-2567.2011.03472.x.

14.

Interleukin-11 drives early lung inflammation during Mycobacterium tuberculosis infection in genetically susceptible mice.

Kapina MA, Shepelkova GS, Avdeenko VG, Guseva AN, Kondratieva TK, Evstifeev VV, Apt AS.

PLoS One. 2011;6(7):e21878. doi: 10.1371/journal.pone.0021878. Epub 2011 Jul 15.

15.

[A locus involved in tuberculosis infection control in mice locates in the proximal part of the H2 complex].

Korotetskaia MV, Kapina MA, Averbakh MM, Evstifeev VV, Apt AS, Logunova NN.

Mol Biol (Mosk). 2011 Jan-Feb;45(1):68-76. Russian.

PMID:
21485498
16.

[Development of pulmonary chlamydia infection in inbred mice lines differentiated by genetically determinated sensitivity to tuberculosis infection].

Nesterenko LN, Aliapkina IuS, Pashko IuP, Kondrat'eva EV, Kapina MA, Balunets DV, Zagangirova NA, Romanova IuM, Apt AS.

Mol Gen Mikrobiol Virusol. 2010;(3):12-6. Russian.

PMID:
20882771
17.

Adaptive Changes in Mycobacterium avium Gene Expression Profile Following Infection of Genetically Susceptible and Resistant Mice.

Ignatov DV, Skvortsov TA, Majorov KB, Apt AS, Azhikina TL.

Acta Naturae. 2010 Jul;2(3):78-83.

18.

B cells delay neutrophil migration toward the site of stimulus: tardiness critical for effective bacillus Calmette-Guérin vaccination against tuberculosis infection in mice.

Kondratieva TK, Rubakova EI, Linge IA, Evstifeev VV, Majorov KB, Apt AS.

J Immunol. 2010 Feb 1;184(3):1227-34. doi: 10.4049/jimmunol.0902011. Epub 2009 Dec 18.

19.

[Immunomorphological characteristics of experimental granulomatous inflammation caused by Mycobacterium avium].

Averbakh MM, Kondrat'eva EV, Apt AS.

Tuberk Biolezni Legkih. 2009;(8):38-41. Russian.

PMID:
19810181
20.

[Study of a role of B cells in the formation of antituberculosis immunity].

Linge IA, Rubakova EI, Shepel'kova GS, Apt AS, Kondrat'eva TK.

Probl Tuberk Bolezn Legk. 2009;(4):39-41. Review. Russian.

PMID:
19514453
21.

[Tuberculosis: pathogenesis, immune responses and genetics of the host].

Apt AS, Kondrat'eva TK.

Mol Biol (Mosk). 2008 Sep-Oct;42(5):880-90. Review. Russian.

PMID:
18988536
22.

I/St mice hypersusceptible to Mycobacterium tuberculosis are resistant to M. avium.

Kondratieva EV, Evstifeev VV, Kondratieva TK, Petrovskaya SN, Pichugin AV, Rubakova EI, Averbakh MM Jr, Apt AS.

Infect Immun. 2007 Oct;75(10):4762-8. Epub 2007 Jul 30.

23.
24.

[Efficiency of anti-inflammatory therapy for experimental tuberculosis in genetically tuberculosis-sensitive mice].

Kondrat'eva TK, Rubakova EI, Evstifeev VV, Sosunov VV, Petrovskaia SN, Kondrat'eva AV, Apt AS.

Probl Tuberk Bolezn Legk. 2006;(10):63-5. Russian.

PMID:
17139836
25.

Mycobacterium tuberculosis-susceptible I/St mice develop severe disease following infection with taxonomically distant bacteria, Salmonella enterica and Chlamydia pneumoniae.

Nesterenko LN, Balunets DV, Tomova AS, Romanova JM, Alyapkina JS, Zigangirova NA, Kapina MA, Kondratieva EV, Pichugin AV, Majorov KB, Apt AS.

Clin Exp Immunol. 2006 Oct;146(1):93-100.

26.

[Experimental approaches to designing vaccines against tuberculous infection reactivation].

Radaeva TV, Nikonenko BV, Kapina MA, Mishchenko VV, Apt AS.

Probl Tuberk Bolezn Legk. 2006;(5):45-8. Russian.

PMID:
16850924
27.

Constitutive differences in gene expression profiles parallel genetic patterns of susceptibility to tuberculosis in mice.

Orlova MO, Majorov KB, Lyadova IV, Eruslanov EB, M'lan CE, Greenwood CM, Schurr E, Apt AS.

Infect Immun. 2006 Jun;74(6):3668-72.

29.

Analysis of cellular phenotypes that mediate genetic resistance to tuberculosis using a radiation bone marrow chimera approach.

Majorov KB, Eruslanov EB, Rubakova EI, Kondratieva TK, Apt AS.

Infect Immun. 2005 Sep;73(9):6174-8.

30.

A new coding mutation in the Tnf-alpha leader sequence in tuberculosis-sensitive I/St mice causes higher secretion levels of soluble TNF-alpha.

Kähler AK, Persson AS, Sánchez F, Källström H, Apt AS, Schurr E, Lavebratt C.

Genes Immun. 2005 Oct;6(7):620-7.

PMID:
16015367
31.

Mutants of Mycobacterium tuberculosis lacking three of the five rpf-like genes are defective for growth in vivo and for resuscitation in vitro.

Downing KJ, Mischenko VV, Shleeva MO, Young DI, Young M, Kaprelyants AS, Apt AS, Mizrahi V.

Infect Immun. 2005 May;73(5):3038-43.

32.

Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice.

Eruslanov EB, Lyadova IV, Kondratieva TK, Majorov KB, Scheglov IV, Orlova MO, Apt AS.

Infect Immun. 2005 Mar;73(3):1744-53.

33.

The OtsAB pathway is essential for trehalose biosynthesis in Mycobacterium tuberculosis.

Murphy HN, Stewart GR, Mischenko VV, Apt AS, Harris R, McAlister MS, Driscoll PC, Young DB, Robertson BD.

J Biol Chem. 2005 Apr 15;280(15):14524-9. Epub 2005 Feb 9.

34.

Direct comparison of low-dose and Cornell-like models of chronic and reactivation tuberculosis in genetically susceptible I/St and resistant B6 mice.

Radaeva TV, Nikonenko BV, Mischenko VV, Averbakh MM Jr, Apt AS.

Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):65-72. Epub 2004 Dec 31.

PMID:
15687029
35.

Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium tuberculosis.

Doherty TM, Olsen AW, Weischenfeldt J, Huygen K, D'Souza S, Kondratieva TK, Yeremeev VV, Apt AS, Raupach B, Grode L, Kaufmann S, Andersen P.

J Infect Dis. 2004 Dec 15;190(12):2146-53. Epub 2004 Nov 8.

PMID:
15551213
36.

Mycobacterial dissemination and cellular responses after 1-lobe restricted tuberculosis infection of genetically susceptible and resistant mice.

Mischenko VV, Kapina MA, Eruslanov EB, Kondratieva EV, Lyadova IV, Young DB, Apt AS.

J Infect Dis. 2004 Dec 15;190(12):2137-45. Epub 2004 Nov 15.

PMID:
15551212
37.

[Genomics and gene engineering: rationale to the development of new means of tuberculosis control].

Kariagina AS, Naroditskiĭ BS, Apt AS, Gintsburg AL.

Zh Mikrobiol Epidemiol Immunobiol. 2004 Jul-Aug;(4):94-101. Review. Russian.

PMID:
15481937
38.

[Induction of an immune response to mycobacterial antigens by means of dendritic cells].

Petrovskaia SN, Rubakova EI, Apt AS, Kondrat'eva TK.

Probl Tuberk Bolezn Legk. 2004;(8):61-3. Russian.

PMID:
15478564
39.

CD4 T cells producing IFN-gamma in the lungs of mice challenged with mycobacteria express a CD27-negative phenotype.

Lyadova IV, Oberdorf S, Kapina MA, Apt AS, Swain SL, Sayles PC.

Clin Exp Immunol. 2004 Oct;138(1):21-9.

40.

Lung cell responses to M. tuberculosis in genetically susceptible and resistant mice following intratracheal challenge.

Eruslanov EB, Majorov KB, Orlova MO, Mischenko VV, Kondratieva TK, Apt AS, Lyadova IV.

Clin Exp Immunol. 2004 Jan;135(1):19-28.

41.

Proteins of the Rpf family: immune cell reactivity and vaccination efficacy against tuberculosis in mice.

Yeremeev VV, Kondratieva TK, Rubakova EI, Petrovskaya SN, Kazarian KA, Telkov MV, Biketov SF, Kaprelyants AS, Apt AS.

Infect Immun. 2003 Aug;71(8):4789-94.

42.

[Genetic monitoring of tuberculous infection severity in mice with complementary inheritance of resistance].

Radaeva TV, Nikonenko BV, Apt AS.

Probl Tuberk. 2002;(10):28-30. Russian.

PMID:
12593165
43.

Different innate ability of I/St and A/Sn mice to combat virulent Mycobacterium tuberculosis: phenotypes expressed in lung and extrapulmonary macrophages.

Majorov KB, Lyadova IV, Kondratieva TK, Eruslanov EB, Rubakova EI, Orlova MO, Mischenko VV, Apt AS.

Infect Immun. 2003 Feb;71(2):697-707.

44.

Multigenic control of disease severity after virulent Mycobacterium tuberculosis infection in mice.

Sánchez F, Radaeva TV, Nikonenko BV, Persson AS, Sengul S, Schalling M, Schurr E, Apt AS, Lavebratt C.

Infect Immun. 2003 Jan;71(1):126-31.

45.

[Genetic aspects of isolating risk groups for tuberculosis].

Apt AS.

Probl Tuberk. 2001;(7):65-8. Review. Russian. No abstract available.

PMID:
11763570
46.

Intranasal BCG vaccination protects BALB/c mice against virulent Mycobacterium bovis and accelerates production of IFN-gamma in their lungs.

Lyadova IV, Vordermeier HM, Eruslanov EB, Khaidukov SV, Apt AS, Hewinson RG.

Clin Exp Immunol. 2001 Nov;126(2):274-9.

47.

Immunological memory in CBA and CBA/N mice after vaccination with Mycobacterium bovis (BCG).

Nikonenko BV, Khaidukov SV, Litvinov IS, Bocharova, Apt AS.

Bull Exp Biol Med. 2001 Jun;131(6):548-9.

PMID:
11586403
48.

Deletion of the 19kDa antigen does not alter the protective efficacy of BCG.

Yeremeev VV, Stewart GR, Neyrolles O, Skrabal K, Avdienko VG, Apt AS, Young DB.

Tuber Lung Dis. 2000;80(6):243-7.

PMID:
11162765
49.

Comparative analysis of T lymphocytes recovered from the lungs of mice genetically susceptible, resistant, and hyperresistant to Mycobacterium tuberculosis-triggered disease.

Lyadova IV, Eruslanov EB, Khaidukov SV, Yeremeev VV, Majorov KB, Pichugin AV, Nikonenko BV, Kondratieva TK, Apt AS.

J Immunol. 2000 Nov 15;165(10):5921-31.

50.

Characterization of T cell clones derived from lymph nodes and lungs of Pseudomonas aeruginosa-susceptible and resistant mice following immunization with heat-killed bacteria.

Kondratieva TK, Kobets NV, Khaidukov SV, Yeremeev VV, Lyadova IV, Apt AS, Tam MF, Stevenson MM.

Clin Exp Immunol. 2000 Aug;121(2):275-82.

Supplemental Content

Support Center